GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Publication Date: 2017-01-23
    Description: Publication date: 20 February 2017 Source: Electrochimica Acta, Volume 228 Author(s): Ilena Grimmer, Paul Zorn, Stephan Weinberger, Christoph Grimmer, Birgit Pichler, Bernd Cermenek, Florian Gebetsroither, Alexander Schenk, Franz-Andreas Mautner, Brigitte Bitschnau, Viktor Hacker La 0.7 Sr 0.3 (Fe 0.2 Co 0.8 )O 3 and La 0.7 Sr 0.3 MnO 3 −based cathode catalysts are synthesized by the sol-gel method. These perovskite cathode catalysts are tested in half cell configuration and compared to MnO 2 as reference material in alkaline direct ethanol fuel cells (ADEFCs). The best performing cathode is tested in single cell setup using a standard carbon supported Pt 0.4 Ru 0.2 based anode. A backside Luggin capillary is used in order to register the anode potential during all measurements. Characteristic processes of the electrodes are investigated using electrochemical impedance spectroscopy. Physical characterizations of the perovskite based cathode catalysts are performed with a scanning electron microscope (SEM) and by X-ray diffraction showing phase pure materials. In half cell setup, La 0.7 Sr 0.3 MnO 3 shows the highest tolerance toward ethanol with a performance of 614 mA cm −2 at 0.65 V vs. RHE in 6 M KOH and 1 M EtOH at RT. This catalyst outperforms the state-of-the-art precious metal-free MnO 2 catalyst in presence of ethanol. In fuel cell setup, the peak power density is 27.6 mW cm −2 at a cell voltage of 0.345 V and a cathode potential of 0.873 V vs. RHE. Graphical abstract
    Print ISSN: 0013-4686
    Electronic ISSN: 1873-3859
    Topics: Chemistry and Pharmacology , Physics
    Published by Elsevier
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Publication Date: 2014-11-28
    Description: Publication date: Available online 24 November 2014 Source: Biochemical and Biophysical Research Communications Author(s): Florian Weinberger , Dennis Mehrkens , Jutta Starbatty , Philipp Nicol , Thomas Eschenhagen Rationale: Islet-1 positive (Islet-1 + ) cardiac progenitor cells give rise to the right ventricle, atria and outflow tract during murine cardiac development. In the adult heart Islet-1 expression is limited to parasympathetic neurons, few cardiomyocytes, smooth muscle cells, within the proximal aorta and pulmonary artery and sinoatrial node cells. Its role in these cells is unknown. Here we tested the hypothesis that Islet-1 + cells retain proliferative activity and may therefore play a role in regenerating specialized regions in the heart. Methods and results: DNA synthesis was analyzed by the incorporation of tritiated thymidine ( 3 H-thymidine) in Isl-1-nLacZ mice, a transgenic model with an insertion of a nuclear beta-galactosidase in the Islet-1 locus. Mice received daily injections of 3 H-thymidine for 5 days. DNA synthesis was visualized throughout the heart by dipping autoradiography of cryosections. Colocalization of an nLacZ-signal and silver grains would indicate DNA synthesis in Islet-1 + cells. Whereas Islet − non-myocyte nuclei were regularly marked by accumulation of silver grains, colocalization with nLacZ-signals was not detected in >25,000 cells analyzed. Conclusions: Islet-1 + cells are quiescent in the adult heart, suggesting that, under normal conditions, even pacemaking cells do not proliferate at higher rates than normal cardiac myocytes.
    Print ISSN: 0006-291X
    Electronic ISSN: 1090-2104
    Topics: Biology , Chemistry and Pharmacology , Physics
    Published by Elsevier
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Publication Date: 2015-11-23
    Description: Publication date: Available online 17 November 2015 Source: Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Author(s): Kaja Breckwoldt, Florian Weinberger, Thomas Eschenhagen Regenerating an injured heart holds great promise for millions of patients suffering from heart diseases. Since the human heart has very limited regenerative capacity, this is a challenging task. Numerous strategies aiming to improve heart function have been developed. In this review we focus on approaches intending to replace damaged heart muscle by new cardiomyocytes. Different strategies for the production of cardiomyocytes from human embryonic stem cells or human induced pluripotent stem cells, by direct reprogramming and induction of cardiomyocyte proliferation are discussed regarding their therapeutic potential and respective advantages and disadvantages. Furthermore, different methods for the transplantation of pluripotent stem cell-derived cardiomyocytes are described and their clinical perspectives are discussed.
    Print ISSN: 0167-4889
    Electronic ISSN: 1879-2596
    Topics: Biology , Chemistry and Pharmacology , Medicine , Physics
    Published by Elsevier
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...